IP Library › Granted Patent US 12,491,146
Granted Patent B1
US 12,491,146 · App. 19/045,297 · Granted Dec 9, 2025

Skin brightening compositions with thiopyridinone compound

Inventors: Catherine Chiou (Saddle Brook, NJ); Hungta Lin (Teaneck, NJ); Mariko Hasebe (New York, NY); Nicholas David Stebbins (Clark, NJ); Ritesh Kumar Sinha (Linden, NJ)
Assignee: L'OREAL
A61K8/4933A61K8/345A61K8/463A61Q19/02A61K2800/28A61K2800/5424
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,491,146
App. No.
19/045,297
Granted
Dec 9, 2025
Kind
B1
Abstract

A cosmetic composition comprising: (a) 2-mercaptonicotinoyl glycine; (b) acyl glycinate surfactant; (c) a salt providing divalent cations having a charge density of about 40 to about 200 C/mm 3 and a water solubility of at least 400 g/L; (d) anionic polymer; (e) glycerin; (f) water; and (g) reducing agent. The cosmetic composition is particularly useful in a method for brightening skin, depigmenting skin, treating hyperpigmentation of skin, treating melasmic skin, or evening skin tone.

Claims (46)

1 . A cosmetic composition comprising:

(a) about 0.05 to about 5 wt. % of 2-mercaptonicotinoyl glycine;

(b) about 5 to about 25 wt. % of one or more acyl glycinate surfactants;

(c) about 0.05 to about 5 wt. % of one or more salts providing divalent cations having a charge density of about 40 to about 200 C/mm3 and a water solubility of at least 400 g/L;

(d) about 0.5 to about 6 wt. % of one or more anionic polymers;

(e) about 35 to about 60 wt. % of glycerin;

(f) about 15 to about 50 wt. % of water; and

(g) about 0.1 to about 3 wt. % of one or more thiosulfate and/or bisulfite reducing agents;

wherein the composition has a viscosity of about 25,000 cP to about 300,000 cP at 25° C. and a shear rate of 1 s − 1, and all percentages by weight are based on a total weight of the composition.

2 . The composition of claim 1 , wherein the one or more acyl glycinate surfactants are selected from sodium cocoyl glycinate, sodium lauroyl glycinate, sodium myristoyl glycinate, potassium lauroyl glycinate, potassium cocoyl glycinate, or a combination thereof.

3 . The composition of claim 1 , wherein the one or more salts providing divalent cations are selected from magnesium salts, calcium salts, or a combination thereof.

4 . The composition of claim 3 , wherein the one or more salts providing divalent cations are selected from magnesium chloride, calcium chloride, magnesium sulfate, magnesium thiosulfate, calcium sulfate, calcium thiosulfate, magnesium pyrrolidone carboxylate, calcium pyrrolidone carboxylate, magnesium gluconate, or a combination thereof.

5 . The composition of claim 1 , wherein the one or more anionic polymers are copolymers of two or more monomers selected from acrylic acid, methacrylic acid, vinyl monomers, and (meth)acrylamide.

6 . The composition of claim 1 , wherein the one or more anionic polymers comprise or consist of acrylates copolymer.

7 . The composition of claim 1 , wherein the one or more thiosulfate and/or bisulfite reducing agents are selected from thiosulfate reducing agents.

8 . The composition of claim 7 , wherein the thiosulfate reducing agents are selected from sodium thiosulfate, potassium thiosulfate, calcium thiosulfate, ammonium thiosulfate, sodium thiosulfite, potassium thiosulfite, and combinations thereof.

9 . The composition of claim 1 , wherein the one or more thiosulfate and/or bisulfite reducing agents are selected from bisulfite reducing agents.

10 . The composition of claim 9 , wherein the bisulfite reducing agents are selected from sodium bisulfite, potassium bisulfite, ammonium bisulfite, sodium metabisulfite, potassium metabisulfite, calcium bisulfite, and combinations thereof.

11 . The composition of claim 1 , wherein the one or more reducing agents is sodium thiosulfate.

12 . The composition of claim 1 , further comprising one or more nonionic emulsifiers having a Hydrophilic-Lipophilic (HLB) of about 6 or less.

13 . The composition of claim 1 having a pH of about 4 to about 7.

14 . The composition of claim 1 , wherein the composition has a lamellar liquid crystal structure.

15 . The composition of claim 1 , wherein (c) and (d) are in a weight ratio of about 1.5:1 to about 1:5 ((c):(d)) and/or (e) and (f) are in a weight ratio of about 1:1 to about 1:2 ((e):(f)).

16 . The composition of claim 1 , wherein the composition retains at least 90 wt. % of the 2-mercaptonicotinoyl glycine after 2 months in storage at 25° C. in a light resistant glass container.

17 . A cosmetic composition consisting of:

(a) about 0.05 to about 5 wt. % of 2-mercaptonicotinoyl glycine;

(b) about 5 to about 25 wt. % of one or more acyl glycinate surfactants;

(c) about 0.05 to about 5 wt. % of one or more salts providing divalent cations having a charge density of about 40 to about 200 C/mm3 and a water solubility of at least 400 g/L;

(d) about 0.5 to about 6 wt. % of acrylates copolymer;

(e) about 35 to about 60 wt. % of glycerin;

(f) about 15 to about 50 wt. % of water; and

(g) about 0.1 to about 3 wt. % of one or more thiosulfate and/or bisulfite reducing agents;

(h) about 1 to about 10 wt. % of one or more nonionic emulsifiers having a Hydrophilic-Lipophilic (HLB) of about 6 or less;

(i) one or more skin active agents;

(j) optionally, one or more humectants selected from glycols having from 2 to about 10 carbon atoms; and

(k) optionally, about 0.01 to about 5 wt. % of one or more miscellaneous ingredients;

wherein the composition has a pH of about 4 to about 7,

the composition has a lamellar liquid crystal structure,

the composition has a viscosity of about 25,000 cP to about 300,000 cP at 25° C. and a shear rate of 1 s − 1, and

all percentages by weight are based on a total weight of the composition.

18 . A method for treating skin comprising applying the composition of claim 1 to the skin.

19 . A method for depigmenting skin, brightening skin, treating hyperpigmentation of skin, treating melasmic skin, evening skin tone, or a combination thereof, the method comprising applying an effective amount of the composition of claim 1 to skin in need thereof.

20 . The method of claim 18 , wherein the composition is applied as a cleanser, as an overnight treatment, or as a face mask, wherein:

when applied as a cleanser, the composition is mixed with water and applied to skin, gently rubbed on the skin, and rinsed from the skin;

when applied as an overnight treatment, the composition is applied to skin and allowed to remain on the skin overnight; and

when applied as a face mask, the composition is applied to skin, allowed to remain on the skin for a period of at least 1 minute before being removed from the skin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2025
From: CHIOU, CATHERINE; LIN, HUNGTA; HASEBE, MARIKO; STEBBINS, NICHOLAS DAVID; SINHA, RITESH KUMAR
To: L'OREAL
Reel/Frame 070107/0693 →
Continuity (1)
Provisional Application 63737499 · Dec 20, 2024
References Cited (40)
US 5888489A · von Mallek · 1999 [cited by applicant]
US 7744655B2 · De Boni et al. · 2010 [cited by applicant]
US 8450260B2 · Crawford et al. · 2013 [cited by applicant]
US 9138392B2 · Marat · 2015 [cited by applicant]
US 9248083B2 · Aires et al. · 2016 [cited by applicant]
US 9408785B2 · Pistorio et al. · 2016 [cited by applicant]
US 10328009B1 · Elsen-Wahrer et al. · 2019 [cited by applicant]
US 10548832B2 · Thomas et al. · 2020 [cited by applicant]
US 10561592B2 · Darras et al. · 2020 [cited by applicant]
US 10912728B2 · D'Arras et al. · 2021 [cited by applicant]
US 11458084B2 · Park et al. · 2022 [cited by applicant]
US 20020176843A1 · Creton · 2002 [cited by applicant]
US 20020182238A1 · Creton · 2002 [cited by applicant]
US 20050158269A1 · Simonet · 2005 [cited by applicant]
US 20050222001A1 · Baumeister et al. · 2005 [cited by applicant]
US 20070128256A1 · Aubrun-Sonneville · 2007 [cited by applicant]
US 20080014162A1 · Willemin et al. · 2008 [cited by applicant]
US 20110171151A1 · Arnaud et al. · 2011 [cited by applicant]
US 20130011360A1 · Viravau et al. · 2013 [cited by applicant]
US 20130210696A1 · Vethamuthu et al. · 2013 [cited by applicant]
US 20150297481A1 · Wahler et al. · 2015 [cited by applicant]
US 20150359722A1 · Thomas et al. · 2015 [cited by applicant]
US 20170113071A1 · Schoepgens · 2017 [cited by examiner]
US 20170189286A1 · George et al. · 2017 [cited by applicant]
US 20170326044A1 · Springinsfeld et al. · 2017 [cited by applicant]
US 20190060196A1 · Elsen et al. · 2019 [cited by applicant]
US 20190216692A1 · Luan et al. · 2019 [cited by applicant]
US 20190290557A1 · Shimizu et al. · 2019 [cited by applicant]
US 20200188282A1 · Chodorowski-Kimmes · 2020 [cited by applicant]
US 20200188283A1 · Chodorowski-Kimmes · 2020 [cited by applicant]
US 20220362128A1 · Hamazaki et al. · 2022 [cited by applicant]
US 20220378683A1 · Stebbins et al. · 2022 [cited by applicant]
CN 116549324A · 2023 [cited by applicant]
EP 2811972B1 · 2016 [cited by applicant]
FR 3136667A1 · 2023 [cited by applicant]
FR 3138036A1 · 2024 [cited by applicant]
FR 3138310A1 · 2024 [cited by applicant]
FR 3143036A1 · 2024 [cited by applicant]
WO 2023249121A1 · 2023 [cited by applicant]
WO 2023249122A1 · 2023 [cited by applicant]